16
FTC Backs Amneal on Unlawful Orange Book Listings
Update: Teva Granted 30-Day Stay on Inhaler Patents’ Orange Book Delisting Last week, a federal judge in New Jersey granted Teva a 30-day stay during a hearing on their request. Amneal, supported by the FTC, has achieved a significant legal victory against Teva by successfully removing Teva’s inhaler patents from the FDA’s Orange Book. Amneal […]